IL13RA2-258C
Optional Service: Optional requirements on this protein
Product Overview :
Recombinant Canine IL13RA2 (Q95LF0) (Met1-Thr338), fused with a C-terminal polyhistidine tag, was produced in Human Cells.
Source :
Human Cells
Species :
Canine
Tag :
His
Predicted N Terminal :
Ser 22
Form :
Lyophilized from sterile PBS, pH 7.4.Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization.
Molecular Mass :
The recombinant canine IL13RA2 comprises 328 amino acids and has a predicted molecular mass of 38.6 kDa. The apparent molecular mass of the protein is approximately 39-46 kDa in SDS-PAGE under reducing conditions due to glycosylation.
Endotoxin :
< 1.0 eu per μg of the protein as determined by the LAL method.
Purity :
>95 % as determined by SDS-PAGE
Stability :
Samples are stable for up to twelve months from date of receipt at -70oC.
Storage :
Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution :
It is recommended that sterile water be added to the vial to prepare a stock solution. Centrifuge the vial at 4oC before opening to recover the entire contents.
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.